Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Nicholson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
International Journal of Microcirculation, Clinical and Experimental|January 1, 1988
The effect of short-term and long-term femoral artery ligation on rat calf muscle oxygen tension, blood flow, metabolism and functionD Angersbach, J J Jukna, C D Nicholson, et al.
European Journal of Pharmacology|February 7, 1991
The lack of utility of the rat vas deferens as a functional bioassay for sigma ligandsP K Fox, J H Connick, G M Hanlon, et al.
British Journal of Pharmacology|November 1, 1992
Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactionsJ H Connick, G Hanlon, J Roberts, et al.
British Journal of Pharmacology|August 1, 1992
Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitorsJ de Boer, A J Philpott, R G van Amsterdam, et al.
British Journal of Pharmacology|October 1, 1991
The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitorsM Shahid, R G van Amsterdam, J de Boer, et al.
American Journal of Hospital Pharmacy|August 15, 1994
Danaparoid is not a low-molecular-weight heparinC D Nicholson, D G Meuleman, H N Magnani, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthmaC D Nicholson, M Shahid, J Bruin, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Microcirculation, Clinical and Experimental|January 1, 1988
The effect of short-term and long-term femoral artery ligation on rat calf muscle oxygen tension, blood flow, metabolism and functionD Angersbach, J J Jukna, C D Nicholson, et al.
European Journal of Pharmacology|February 7, 1991
The lack of utility of the rat vas deferens as a functional bioassay for sigma ligandsP K Fox, J H Connick, G M Hanlon, et al.
British Journal of Pharmacology|November 1, 1992
Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactionsJ H Connick, G Hanlon, J Roberts, et al.
British Journal of Pharmacology|August 1, 1992
Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitorsJ de Boer, A J Philpott, R G van Amsterdam, et al.
British Journal of Pharmacology|October 1, 1991
The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitorsM Shahid, R G van Amsterdam, J de Boer, et al.
American Journal of Hospital Pharmacy|August 15, 1994
Danaparoid is not a low-molecular-weight heparinC D Nicholson, D G Meuleman, H N Magnani, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthmaC D Nicholson, M Shahid, J Bruin, et al.
Pageof 4